Q3 EPS Forecast for LENZ Therapeutics Boosted by Analyst
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Stock analysts at Leerink Partnrs raised their Q3 2025 earnings per share (EPS) estimates for LENZ Therapeutics in a report released on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now expects that the company will earn ($0.80) per share for the quarter, up from their previous […]
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Stock analysts at Leerink Partnrs raised their Q3 2025 earnings per share (EPS) estimates for LENZ Therapeutics in a report released on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now expects that the company will earn ($0.80) per share for the quarter, up from their previous […]
